Details for Patent: 11,285,098
✉ Email this page to a colleague
Which drugs does patent 11,285,098 protect, and when does it expire?
Patent 11,285,098 protects ZELSUVMI and is included in one NDA.
This patent has fifteen patent family members in seven countries.
Summary for Patent: 11,285,098
Title: | Topical compositions and methods of using the same |
Abstract: | The present invention relates generally to compositions and methods of using the same. |
Inventor(s): | Doxey Ryan, Sabouni Adam, Kougoulos Eleftherios, Stasko Nathan |
Assignee: | Novan, Inc. |
Application Number: | US16267738 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 11,285,098
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lnhc | ZELSUVMI | berdazimer sodium | GEL;TOPICAL | 217424-001 | Jan 5, 2024 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,285,098
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2014223164 | ⤷ Try a Trial | |||
Brazil | 112015019657 | ⤷ Try a Trial | |||
Canada | 2900557 | ⤷ Try a Trial | |||
Canada | 3133526 | ⤷ Try a Trial | |||
China | 105392472 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |